GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in medical studies, largely due to its notable impact on managing conditions such as adult-onset diabetes and weight gain. Recent trials have shown that beyond glucose regulation, GLP-1 drugs offer promise for heart health and perhaps cognitive diseases